1.
Chem Commun (Camb)
; 51(18): 3816-9, 2015 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25648900
RESUMO
DC-SIGN antagonists were designed combining one selective monovalent glycomimetic ligand with trivalent dendrons separated by a rigid core of controlled length. The design combines multiple multivalency effects to achieve inhibitors of HIV infection, which are active in nanomolar concentration.